Apricitabine (INN codenamed AVX754 and SPD754 sometimes abbreviated to ATC) is an experimental nucleoside reverse transcriptase inhibitor (NRTI) against HIV. It is structurally related to lamivudine and emtricitabine and like these is an analogue of cytidine.
This page contains content from the copyrighted Wikipedia article "Apricitabine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.